1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Guangdong Zhongsheng Pharmaceutical Co., Ltd.
  6. News
  7. Summary
    002317   CNE100000HW4

GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD.

(002317)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-06-30
14.19 CNY   -2.21%
05/23Guangdong Zhongsheng Pharmaceutical Co., Ltd. Announces Cash Dividend, Payable on May 27, 2022
CI
05/18Guangdong Zhongsheng Pharmaceutical Co., Ltd. Approves Final Cash Dividend for the Year 2021
CI
05/16Zhongsheng Pharma Wins Nod in China to Start Clinical Trial of Oral COVID-19 Drug; Shares Fall 10%
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Zhongsheng Pharmaceutical Files Clinical Trial Application For COVID-19 Drug; Shares Slide 4%

05/12/2022 | 11:50pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD. -2.21% 14.19 End-of-day quote.17.37%
ZHONGSHENG GROUP HOLDINGS LIMITED -0.90% 55.35 Delayed Quote.-8.96%
All news about GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD.
05/23Guangdong Zhongsheng Pharmaceutical Co., Ltd. Announces Cash Dividend, Payable on May 2..
CI
05/18Guangdong Zhongsheng Pharmaceutical Co., Ltd. Approves Final Cash Dividend for the Year..
CI
05/16Zhongsheng Pharma Wins Nod in China to Start Clinical Trial of Oral COVID-19 Drug; Shar..
MT
05/12Zhongsheng Pharmaceutical Files Clinical Trial Application For COVID-19 Drug; Shares Sl..
MT
04/26Guangdong Zhongsheng Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year..
CI
04/25Guangdong Zhongsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Qu..
CI
2021Guangdong Zhongsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Mon..
CI
2021Guangdong Zhongsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Yea..
CI
2021Tranche Update on Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s Equity Buyback Plan a..
CI
2021Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s Equity Buyback announced on February 8,..
CI
More news
Financials
Sales 2021 2 429 M 362 M 362 M
Net income 2021 278 M 41,4 M 41,4 M
Net cash 2021 779 M 116 M 116 M
P/E ratio 2021 34,5x
Yield 2021 1,65%
Capitalization 11 316 M 1 689 M 1 689 M
EV / Sales 2020 4,19x
EV / Sales 2021 3,65x
Nbr of Employees 1 626
Free-Float 65,2%
Chart GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD.
Duration : Period :
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Managers and Directors
Yong Hong Chen Chairman & General Manager
Chun Hua Long CFO, Director, Head-Accounting & Deputy GM
Su xian Li Member-Supervisory Board
Chao Feng Long Director & Deputy General Manager
Chen Huan Ding Member-Supervisory Board